Frekil provides a professional medical image annotation platform utilizing AI-powered DICOM annotation tools. Their services cater to radiology workflows, healthcare AI development, and clinical research. The platform is designed to support various medical imaging needs.
Co-founder & CEO
Co-founder & CTO
Frekil's main competitors in the healthcare and medical imaging analytics market include Qure.ai, Perspectum, and AIdoc.
Qure.ai specializes in AI-based image analysis tools for clinical labs and has raised $123 million in funding. Its advantage lies in its advanced AI technology that enhances diagnostic accuracy and efficiency in medical imaging.
Perspectum focuses on precision medicine software specifically for liver disease diagnosis, with $140 million in funding. Its notable advantage is its specialized approach to liver health, providing tailored solutions for healthcare providers.
AIdoc offers AI-based systems designed to streamline medical imaging processes and has raised $274 million. Its strength is in automating workflows and improving the speed of diagnosis, which can significantly benefit healthcare facilities.
These competitors have established significant funding and specialized offerings that differentiate them in the market compared to Frekil, which is still in its early stages with $500K in funding.
Frekil primarily focuses on the healthcare industry, specifically in medical imaging analytics. The company provides an AI-assisted platform that speeds up the annotation of medical images, aiming to streamline the process for clinical trials and AI training.